Medtronic closed at $104.96 on Nov 4, up 6.15%, 0.4% below its 52-week closing high. Volume of 11.6M shares was 0.45× its 20-day average (below normal).
Split-adjusted performance: +20.5% over one month, +35.3% over six months, +16.4% over one year.
In the quarter ended Jul 31, 2026, revenue was $9.76B, up 13.7% from a year earlier, with a net margin of 15.1%.
Short interest was 139.0M shares at the Oct 15 settlement, up 247.7% from the prior report (10.9% of float, 2.9 days to cover).